Home > In process > In-Source Fragmentation Annotation in Sterol Mass Spectrometry Imaging. > print

001     283220
005     20260116093310.0
024 7 _ |a 10.1021/acs.analchem.5c05199
|2 doi
024 7 _ |a pmid:41408757
|2 pmid
024 7 _ |a 0003-2700
|2 ISSN
024 7 _ |a 0096-4484
|2 ISSN
024 7 _ |a 1520-6882
|2 ISSN
024 7 _ |a 1541-4655
|2 ISSN
037 _ _ |a DZNE-2026-00069
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Sidorov, Iulia
|0 0009-0004-6998-4690
|b 0
245 _ _ |a In-Source Fragmentation Annotation in Sterol Mass Spectrometry Imaging.
260 _ _ |a Columbus, Ohio
|c 2026
|b American Chemical Society
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1768552242_4731
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Spatial biology has emerged as a pivotal area in many life science fields, with mass spectrometry imaging (MSI) becoming a cornerstone for molecular imaging. Among recent advancements to increase sensitivity, MALDI-2 technology has significantly expanded the molecular space accessible to MSI, increasing the ion yields of neutral metabolites, such as sterols. Sterols have recently taken center stage in numerous (patho-) physiological processes, including neurodegenerative diseases that have attracted significant scientific interest. However, in-source fragmentation (ISF) poses a substantial challenge for accurate biological interpretation of mass spectrometric data. In this study, we observed and investigated the ISF of cholesterol during MSI under MALDI and MALDI-2 conditions. Using a murine intervention model, we demonstrate how ISF can compromise the accuracy of biological interpretations, potentially leading to significant misinterpretations. Our study underscores the critical need to address ISF to ensure accurate molecular annotation, particularly through tandem mass spectrometry of in-source fragments. This is especially important when using MALDI-2 techniques. Furthermore, we introduce a high-resolution (5 μm) MSI technique, enabling the precise spatial analysis of cholesterol distribution.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Cholesterol
|0 97C5T2UQ7J
|2 NLM Chemicals
650 _ 7 |a Sterols
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization: methods
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Cholesterol: analysis
|2 MeSH
650 _ 2 |a Cholesterol: metabolism
|2 MeSH
650 _ 2 |a Sterols: analysis
|2 MeSH
650 _ 2 |a Sterols: chemistry
|2 MeSH
650 _ 2 |a Molecular Imaging: methods
|2 MeSH
700 1 _ |a Ogrinc, Nina
|0 0000-0002-0773-0095
|b 1
700 1 _ |a Spieth, Lena
|0 P:(DE-2719)9002306
|b 2
|u dzne
700 1 _ |a Kopcil, Michal
|b 3
700 1 _ |a Heijink, Marieke
|b 4
700 1 _ |a Dalebout, Hans
|b 5
700 1 _ |a Saher, Gesine
|b 6
700 1 _ |a Berghoff, Stefan A
|0 P:(DE-2719)9001700
|b 7
|u dzne
700 1 _ |a Siuzdak, Gary
|0 0000-0002-4749-0014
|b 8
700 1 _ |a Giera, Martin
|0 0000-0003-1684-1894
|b 9
773 _ _ |a 10.1021/acs.analchem.5c05199
|g Vol. 98, no. 1, p. 509 - 518
|0 PERI:(DE-600)1483443-1
|n 1
|p 509 - 518
|t Analytical chemistry
|v 98
|y 2026
|x 0003-2700
856 4 _ |u https://pub.dzne.de/record/283220/files/DZNE-2026-00069_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/283220/files/DZNE-2026-00069_Restricted.pdf?subformat=pdfa
|x pdfa
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002306
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9001700
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANAL CHEM : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-09
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-09
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ANAL CHEM : 2022
|d 2024-12-09
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21